Antitumour combinations containing a vegf inhibiting agent and irinotecan

• 收藏
• 分享

专利权人:

AVENTIS PHARMA S.A.

发明人:

申请号：

IL24096515

公开号：

IL240965D0

申请日:

2015.08.31

申请国别(地区):

IL

年份:

2015

代理人:

摘要：

Combination (I) comprises vascular endothelial growth factor (VEGF) inhibitor with irinotecan therapeutically used in the treatment of neoplastic diseases. An independent claim is included for a product comprising VEGF inhibitor and irinotecan, as a combined preparation for simultaneous, separated or spread use in the anticancer therapy. ACTIVITY : Cytostatic. MECHANISM OF ACTION : Vascular endothelial growth factor inhibitor Topoisomerase inhibitor.Combinaisons antitumorales constituées dinhibiteur de VEGF associés à lirinotecan thérapeutiquement utiles dans le traitement des maladies néoplastiques.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/